{"certainAgreement":{"piSponsorEmployee":true,"restrictiveAgreement":false},"limitationsAndCaveats":{"description":"After 1 patient was recruited, this trial temporarily closed to allow the first dose of Anti-thymocyte Globulin to be split over two days. Before the modification was written, it was decided to permanently close this study due to competing trials."},"pointOfContact":{"email":"kumar.shaji@mayo.edu","organization":"Mayo Clinic","title":"Dr. Shaji Kumar"}}